Company's Lead Joint Researcher Professor Perán to Present Latest PRP Research Propanc Biopharma, Inc. (OTC Pink: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company developing novel
Current Research Shows Proenzymes Decreases Cell Proliferation and Migration, Induces Cell Differentiation, Impairs Angiogenesis and Reduces the Metastatic Potential of Cancer Stem CellsMELBOURNE, Australia (BUSINESS WIRE) Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering